Login to Your Account

Breaking the Bones of the Cell

Two Studies Describe How Taxol Resistance Develops

By Anette Breindl

Thursday, March 3, 2011
Two groups of scientists – led by researchers from Genentech Inc. and Beth Israel Deaconess Medical Center, respectively – have reported on why some cancer cells are resistant to drugs, such as Taxol, that target microtubules. Such drugs are among the most widely prescribed chemotherapeutic agents.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription